Search

everythinglearnresearchcommunity

for

Search:↓

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Some chemicals absorbed through the skin can cause serious health problems.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Some nonsurgical hair loss treatments are effective, especially if started early.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

A male with aromatase deficiency improved bone health with estradiol treatment.

Psychotropic medications can cause skin problems but also treat some skin conditions.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

The review suggests that understanding and treating the psychological aspect of skin disorders is important and calls for more collaboration in this field.

The document suggests a young mother use effective contraception like the Copper-T IUD while considering her health and the need for STD prevention.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Many adult women suffer from persistent or late-onset acne, and while various treatments exist, finding the right one can be challenging.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Biotin supplements are not proven to improve hair or nails and may interfere with medical tests.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Spironolactone is effective and safe for treating hair loss, excessive hair growth, and acne.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

The conclusion is that dermatologists need to improve prescription practices to reduce errors and drug interaction risks.